Ida Araya-Brumskine

The Rule 144A offering involved 0% exchangeable notes due 2026

We advised the underwriters on the investment-grade notes offering

We advised the initial purchasers on the high-yield notes offering

We advised Perion, whose shares are listed on Nasdaq and the Tel Aviv Stock Exchange

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.5 billion aggregate principal amount of 2.746% senior non-preferred fixed-rate notes due 2025…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by First American Financial Corporation of …

Davis Polk advised the initial purchasers in connection with a concurrent Rule 144A/Regulation S offering by NCLC of $675 million aggregate principal amount of its 12.250% senior…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Norwegian Cruise Line Holdings Ltd. (“NCLH”) of 41,818,181 of its ordinary shares (including 5,454…

Davis Polk also advised the initial purchasers in connection with a concurrent Rule 144A offering by NCL Corporation Ltd. (“NCLC”) of $862.5 million aggregate principal amount of its 6…